We found CDK2/4/6 expression was particularly up-regulated in melanoma, glioblastoma, breast, colon, lung adenocarcinoma, head and neck, pancreatic, liver, and prostate cancer cohorts, compared to the adjacent normal tissues. The gene discussed is CDK2; the disease is prostate carcinoma.